Data / Form D filings / NanoCellect Biomedical, Inc.
NanoCellect Biomedical, Inc.: Form D filings
NanoCellect Biomedical, Inc., a biotechnology company in San Diego, CA, filed 7 Form D notices with the SEC between 2015 and 2023. The latest, on June 30, 2023, reports $28.9 million sold of a $38.5 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9525 Towne Centre Drive, #150, San Diego, CA, 92121
- Phone
- (858) 614-6409
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1658031
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | New notice | $38,504,239 | $28,929,239 | $9,575,000 | 32 | Jun 16, 2023 | sec.gov |
| Aug 27, 2021 | New notice | $20,000,001 | $20,000,001 | 15 | Aug 13, 2021 | sec.gov | |
| Dec 5, 2017 | New notice | $7,500,000 | $7,432,996 | $67,004 | 11 | Nov 22, 2017 | sec.gov |
| Jul 24, 2017 | Amendment | $3,000,000 | $2,466,500 | $533,500 | 4 | Aug 26, 2016 | sec.gov |
| Sep 2, 2016 | New notice | $2,000,000 | $500,000 | $1,500,000 | 1 | Aug 26, 2016 | sec.gov |
| Jan 22, 2016 | Amendment | $1,750,000 | $1,750,000 | 3 | Oct 30, 2015 | sec.gov | |
| Nov 13, 2015 | New notice | $1,500,048 | $500,001 | $1,000,047 | 1 | Oct 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jose Morachis | Executive Officer | |
| Nicolas Barthelemy | Director | |
| Chris Neary | Executive Officer, Director | |
| Paul Conley | Director | |
| Jeremy Baker | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 26, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NanoCellect Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.